section name header

Basics

Outline


BASICS

Definition!!navigator!!

Alloimmune-mediated destruction of a neonatal foal's erythrocytes, caused by ingesting maternally (colostral) derived anti-foal erythrocyte antibodies.

Pathophysiology!!navigator!!

  • Requires that a naive mare is sensitized to a new RBC antigenic sequence during blood transfusion or exposure to fetal RBCs that express the new antigenic sequence. Exposure may occur at parturition, or secondary to in utero disease such as placentitis
  • During a subsequent pregnancy, the foal inherits the same stallion's RBC surface antigen
  • At birth, the foal ingests antibody-rich colostrum and absorbs anti-foal RBC antibodies that cause destruction of RBCs
  • Antibodies attach to the foal erythrocytes causing hemolysis and/or premature removal of damaged RBCs by the reticuloendothelial system
  • Results in anemia

Systems Affected!!navigator!!

  • Hemic/lymphatic/immune—intravascular and extravascular hemolysis leading to anemia, jaundice, and hemoglobinemia
  • Renal/urologic—hemoglobinuria leading to pigment nephropathy, acute tubular necrosis, and acute kidney injury
  • Cardiovascular—tachycardia from hypoxic anemia
  • Nervous—hypoxic anemic shock causing weakness; hyperbilirubinemia causing basal ganglia dysfunction and seizures (kernicterus)
  • Hepatic—liver failure development associated with high-volume blood transfusion

Genetics!!navigator!!

  • There are many RBC surface antigen factors, and in theory any of these can be involved in NI development. However, Aa in the A system and Qa in the Q system represent the majority of cases
  • In mules, the “donkey factor,” which is unique to all donkeys and not horses, is commonly involved

Incidence/Prevalence!!navigator!!

  • Among Thoroughbreds and Standardbreds, the prevalence of disease is 1–2%
  • In mule foals, the prevalence is as high as 10–25%
  • Breed variability reflects the frequency of specific genes involved in erythrocyte antigenicity or blood groups found in each breed
  • Most horse mares bred to donkey jacks are at high risk (see Risk Factors)

Geographic Distribution!!navigator!!

Worldwide

Signalment!!navigator!!

Breed Predilections

  • The antigenic factors are not specific for, or limited to, any particular breed of horse
  • Most mule pregnancies are incompatible regarding the blood group factor, “donkey factor,” in which donkeys express and horses do not

Mean Age and Range

  • Usually foals born to multiparous mares
  • Most foals present during the first 4 days of life (mean range 0–8 days)

Predominant Sex

Both sexes are equally affected.

Signs!!navigator!!

General Comments

The severity of clinical signs varies depending on the magnitude and rate of hemolysis.

Historical Findings

  • Affected foals are generally healthy at birth and nurse appropriately
  • Nonspecific signs such as lethargy begin within hours to days of colostral ingestion and immunoglobulin absorption. These signs may mimic other common neonatal disorders such as septicemia
  • Icterus and generalized pallor soon develop
  • Mare may have a history of producing jaundiced or NI-confirmed foals from previous pregnancies, especially if the same stallion had sired these foals
  • Mare history of previous blood or other blood transfusion

Physical Examination Findings

  • Lethargy, disinterest in suckling
  • Tachypnea; tachycardia
  • Pallor (acute stages) often progressing to jaundice
  • Pigmenturia (hemoglobinuria)
  • Recumbency
  • Mild fever is often present
  • Systemic signs of hypoxic insult and/or hyperbilirubinemia including colic, melena, and seizure activity (hypoxia; kernicterus)

Causes!!navigator!!

Maternal production of anti-foal erythrocyte immunoglobulin from exposure of incompatible fetal blood.

Risk Factors!!navigator!!

  • Mares lacking erythrocyte factors Aa and/or Qa are at greater risk (>90%) of producing antibodies to these blood types
  • Donkey RBC antigen, “donkey factor”—the risk of an incompatible mating between a horse and a donkey (or the chance of a mare becoming sensitized to this antigen) is 100%. Because clinical NI in mule foals only occurs 8–10% of the time, it is suggested that many mule foals may have subclinical NI

Diagnosis

Outline


DIAGNOSIS

Differential Diagnosis!!navigator!!

  • Anemia due to blood loss
  • Hepatopathy—icterus may be present but severe anemia is usually not present with hepatic disease
  • Neonatal maladjustment syndrome—weakness, lethargy present; icterus and anemia should differentiate
  • Neonatal septicemia—icterus, leukocytosis/leukopenia, and weakness may be present, but significant anemia is uncommon with septicemia
  • In endemic areas, consider neonatal babesiosis (piroplasmosis)

CBC/Biochemistry/Urinalysis!!navigator!!

  • Anemia—decreased PCV (usually <20%), decreased hemoglobin concentration, and decreased erythrocyte number
  • Hemoglobinemia
  • Hemoglobinuria
  • Hyperbilirubinemia (primarily indirect, unconjugated fraction); kernicterus is associated with total bilirubin >20 mg/dL
  • Mild leukocytosis
  • Mild thrombocytosis
  • Hypoglycemia is often present

Other Laboratory Tests!!navigator!!

  • Coombs testing (direct antiglobulin test)—detects antierythrocyte factor in mare's serum and colostrum
  • JFA test—this is a field screen test to detect NI. The foal's RBCs are exposed to the mare's colostrum or serum
  • Saline agglutination or complement-mediated hemolytic test can be performed by some laboratories

Diagnostic Procedures!!navigator!!

Foal IgG determination—clinical evidence of jaundice with complete failure of transfer of passive immunity makes NI less likely.

Pathologic Findings!!navigator!!

  • If the foal dies acutely, pallor and icterus may be observed throughout the body. If the foal dies later, the conversion of free hemoglobin to bilirubin leads to widespread jaundice of the body
  • Splenomegaly
  • Pigment nephropathy related to hemoglobinuric nephrosis
  • Bone marrow hypoplasia

Treatment

Outline


TREATMENT

Aims!!navigator!!

  • Restore oxygen-carrying capacity with transfusion of whole blood, packed RBCs, or hemoglobin-based oxygen carrier
  • Prevent further intake of maternal colostrum

Appropriate Health Care!!navigator!!

  • If the foal is showing signs of icterus and lethargy/weakness, emergency inpatient intensive care management may be required, including blood transfusion
  • If there is early recognition of the problem, withholding further maternal colostrum and providing supportive care in the field may be adequate

Nursing Care!!navigator!!

Blood Transfusion

  • Blood transfusion with packed RBCs should be considered in foals where the PCV is <12–15% and/or the foal is showing clinical signs of decompensating anemic hypoxia. Transfusion is not essential to all cases of NI, only those where it is considered a life-saving measure
  • Washed RBCs from the mare are ideal. The stallion is the most unsuitable blood donor
  • A healthy gelding with no previous history of transfusion or a previously blood-typed animal negative for Aa or Qa antibodies is also a suitable blood donor
  • For a 50 kg foal, give whole blood 2–4 L slowly over 1–2 h or packed erythrocytes 1–2 L slowly over 1–2 h

Intranasal Oxygen

Nasal insufflation with humidified oxygen (5–10 L/min) may be used although this is not a substitute for transfusion in severely anemic foals.

Additional Treatments

  • Balanced polyionic crystalloid fluids to promote renal perfusion and diuresis (with or without diuretic medication) for pigment nephropathy
  • Deferoxamine has been given to foals to help prevent hepatic iron accumulation. Plasma exchange has been reported as a treatment of life-threatening hyperbilirubinemia and kernicterus

Activity!!navigator!!

Foals should not be stressed and exercise should be at a minimum to conserve oxygen.

Diet!!navigator!!

  • If recognized before 24 h of age, the foal should be muzzled to prevent further ingestion of colostral antibodies. The mare should be milked out and the milk discarded
  • Affected foals should be supplemented with mare's milk replacer for the first 24–36 h from birth; then resume nursing from the mare

Client Education!!navigator!!

Mares of NI foals are likely to produce NI foals in subsequent pregnancies, especially if the same stallion is used. Preventative strategies should be exercised to minimize the chance of having an NI foal.

Medications

Outline


MEDICATIONS

Drug(s) of Choice!!navigator!!

Seizure control where appropriate.

Precautions!!navigator!!

  • Cautiously administer plasma transfusions when serum IgG concentrations are low. Frequent assessment for disease exacerbation (i.e. hemolytic crisis) is necessary
  • Nephrotoxic drugs such as aminoglycoside antimicrobials and NSAIDs should be avoided

Follow-up

Outline


FOLLOW-UP

Patient Monitoring!!navigator!!

  • CBC, PCV, and lactate to monitor anemia. In acute cases, monitoring may be required every 4–8 h
  • Heart rate, arterial oxygen levels, venous oxygen pressure, oxygen extraction ratio, and attitude are also useful for determining response to therapy
  • Blood urea nitrogen and creatinine concentrations to monitor pigment nephropathy

Prevention/Avoidance!!navigator!!

  • Blood type to identify broodmares that are negative for the Qa and/or Aa erythrocyte antigens and sires that are positive for the Qa and Aa antigens. Avoid breeding negative mares to positive stallions to reduce the chance of NI
  • Determine the probability of NI in potentially incompatible matings. The mare's serum is collected 2 weeks prior to parturition and tested against known blood cell groups or against the sire's RBCs. The presence of hemolysis or agglutination suggests that NI will develop
  • In high-risk cases, withhold the mare's colostrum from the foal and feed colostrum from another low-risk mare. The foal should be foster fed for 2–3 days until gut closure occurs
  • Perform a JFA test. Positive reactions at 1:16 or greater suggest incompatibility and the risk of NI

Possible Complications!!navigator!!

  • Renal failure due to pigment nephropathy
  • Cerebral hypoxia and/or kernicterus with neurologic sequelae
  • Secondary septicemia
  • Liver failure

Expected Course and Prognosis!!navigator!!

  • Peracute cases—prognosis is grave due to the rapidity of onset and severity of disease
  • Acute cases—prognosis is good providing early recognition and diagnosis are established and appropriate therapy is instituted
  • Subacute cases–prognosis is excellent. Even without treatment, most foals are expected to survive. Prognosis is guarded if kernicterus, liver failure, or sepsis-related complications occur. Foals administered large volume blood products are at higher risk of liver failure

Miscellaneous

Outline


MISCELLANEOUS

Associated Conditions!!navigator!!

  • Neonatal immune-mediated thrombocytopenia
  • Evans syndrome
  • Alloimmune neonatal neutropenia

Age-Related Factors!!navigator!!

Affected foals are typically 2–3 days of age at the onset of clinical signs.

Synonyms!!navigator!!

  • Hemolysis of newborns
  • Jaundiced foal disease

Abbreviations!!navigator!!

  • IgG = immunoglobulin G
  • JFA = jaundice foal agglutination test
  • NI = neonatal isoerythrolysis
  • NSAID = nonsteroidal anti-inflammatory drug
  • PCV = packed cell volume
  • RBC = red blood cell

Suggested Reading

Boyle AG, Magdesian KG, Ruby RE. Neonatal isoerythrolysis in horse foals and a mule foal: 18 cases (1988–2003). J Am Vet Med Assoc 2005;227:12761283.

Polkes AC, Giguere S, Lester GD, Bain FT. Factors associated with outcome in foals with neonatal isoerythrolysis (72 cases, 1988-2003). J Vet Intern Med 2008;22:12161222.

Traub-Dargatz JL, McClure JJ, Koch C, Schlipf Jr JW. Neonatal isoerythrolysis in mule foals. J Am Vet Med Assoc 1995;206:6770.

Author(s)

Author: Samuel D.A. Hurcombe

Consulting Editor: Margaret C. Mudge